Path: ...!weretis.net!feeder6.news.weretis.net!feeder8.news.weretis.net!eternal-september.org!feeder3.eternal-september.org!news.eternal-september.org!.POSTED!not-for-mail
From: Geo <Geo@invalid.pasdepub>
Newsgroups: fr.misc.actualite.covid19
Subject: Re: =?ISO-8859-15?Q?ARN,_antibiotiques_:_les_r=E9v=E9lations_excl?=
	=?ISO-8859-15?Q?usives_du_professeur_Raoult_!?=
Date: Wed, 17 Jan 2024 19:20:24 +0100
Organization: A noiseless patient Spider
Lines: 22
Message-ID: <mn.8c887e811ccb5f9b.119180@invalid.pasdepub>
References: <65a58b97$0$2566$426a74cc@news.free.fr> <uo43nm$12egg$1@dont-email.me> <65a59a57$0$16352$426a74cc@news.free.fr> <iLe6LmBnovK21a3H5b835jFlC4A@jntp> <65a673ff$0$7524$426a74cc@news.free.fr> <N8agOErrczBDmWylw7WYW2397wc@jntp> <65a676ad$0$7524$426a74cc@news.free.fr> <7lA7UGyoFgAfKZHcL7WTqBZqHNQ@jntp> <65a678e7$0$2999$426a74cc@news.free.fr> <DNDHE758hwLglvf7vm06lSl8mH4@jntp> <65a6e649$0$8252$426a74cc@news.free.fr> <uo83mq$1tv46$1@dont-email.me> <65a818f2$0$29758$426a74cc@news.free.fr>
MIME-Version: 1.0
Content-Type: text/plain; charset="utf-8"; format=flowed
Content-Transfer-Encoding: 8bit
Injection-Info: dont-email.me; posting-host="90557faa236d34d35c06de28f0ece35c";
	logging-data="2268919"; mail-complaints-to="abuse@eternal-september.org";	posting-account="U2FsdGVkX19fUE2Jd4s1RpKQrlPynlbt"
Cancel-Lock: sha1:h1gfh4sxxqhcR8H1nK7/x5m7itU=
X-Newsreader: MesNews/1.08.06.00
X-Face: 7Npr]YtaiRF.daNb$#]VN~Ph+$EZ@Vqao9W^*/2QgAYbsUU<]PPY}sIP@pph?LD;`I?poD7 =nir>(V(e{!5$QoRr;:&-"u3~RY><)
Bytes: 2902

De Le très baratineur Luciole135, le 17/01/2024 :

> Le 17/01/2024 à 9:38, bruno a écrit :
>> We searched Pubmed, from 1st December 2019, to 15th March 2021, using the 
>> keywords "coronavirus", "severe acute respiratory syndrome 2 coronavirus", 
>> "SARS-CoV-2", "novel coronavirus", "nCoV", "2019-nCoV" and "COVID-19" and 
>> "cohort". From Pubmed, we selected studies according to the following 
>> inclusion criteria: multicentre study, study size ≥ 500 patients to avoid 
>> centre effect, study reporting the treatments used in COVID-19 and the 
>> number of patients treated with these drugs. Studies including only 
>> patients receiving HCQ, receiving HCQ from August 2020 onwards, and 
>> patients already treated with HCQ for autoimmune conditions were excluded, 
>> as well as studies from countries for which mortality data were lacking.
>
> Qu'est-ce que vous ne comprenez pas dans le fait que cette projection, 
> puisqu'il s'agit d'une projection et non pas d'une étude observationnelle ait 
> sélectionné 44 études sur 7748, ce qui la rend non significative.
> Sachant de plus qu'une projection ne peut pas par essence signifier quoi que 
> ce soit.

Un échantillon de moins de 30 personnes ne vous choque pas quand c'est 
Raoult qui en tire des conclusions universelles.